USD10
NXTC 股股份
關於 NextCureNextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
USD10
NXTC 股股份
關於 NextCureNextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
數據
交易窗口
已關閉
開盤時間
沒有足夠的資料
市值
US$2965.26万
開盤價
US$5.27
低 (1 年)
US$1.55
高 (1 年)
US$15.74
低 (24 小時)
US$5.15
24 小時高價
US$5.91
成交量（24 小時）
US$31.59万
68.56%
價格歷史記錄
時間 | 價格 | 變更 |
|---|---|---|
今天 | US$5.27 | |
1 天 | US$5.59 | |
1 週 | US$4.21 | |
1 個月 | US$1.87 | |
1 年 | US$4.80 |
發現更多
法律
所有證券和投資均由 FINRA/SIPC 會員 Coinbase Capital Markets Corp 提供。證券服務由 Coinbase Capital Markets Corp 提供，與 Coinbase Inc. 提供的數位資產服務、任何關聯公司或 Coinbase Luxembourg S.A. 根據 MiCA 提供的加密資產服務是分開的。SIPC 不適用於您在 Coinbase Inc. 帳戶中持有的數位資產或現金。有關您的經紀商 Coinbase Capital Markets Corp 的其他資訊可在 FINRA 的 BrokerCheck 上找到。所有證券的執行、結算和保管均由 Apex Clearing Corporation 提供。本頁面及其內容僅供參考之用，並不構成投資建議的提供。客戶對其交易活動承擔全部責任，並應就其特定情況諮詢其顧問。本材料並非 (i) 投資、購買或出售任何權益或股份，或參與任何投資或交易策略的要約或招攬，(ii) 旨在提供會計、法律或稅務建議，或投資建議。這些資訊會以截至發行日期當下所能獲得的最新資訊出版，且編撰團隊可能不會更新或是以其他的方式修訂內文資訊，所以在出版日期之後，這裡的資訊可能不會確實反映現實生活中可能會迎來的實際情況與變化。所有投資均涉及風險，且證券或金融產品的過往表現不保證未來的結果或回報。當您投資證券或其他金融產品時，總是有可能虧損。投資人在投資前應仔細考慮其投資目標與風險。接收方應該在做出任何投資決定之前先向他們的顧問諮詢。所有 Ticker 名稱皆為其持有人所屬商標。任何 Ticker 參考並不暗示與第三方有任何從屬關係或得到第三方的認可。並非所有市場的即時報價和/或交易價格都來源於此，來源：那斯達克最後成交。Morningstar 資料 ©2026。